Add BrightSurf on Google Email

Science News Archive 2018 - Page 365


Page 365 of 473

A football coach's overconfidence has a positive impact on the team's result

Researchers found that a football coach's extreme overconfidence has a positive influence on the team's result. The study analyzed the behavior of coaches in the Russian Football Premier League and concluded that high levels of charisma associated with overconfidence can motivate players, leading to better team performance.

SourceNational Research University Higher School of Economics·JournalInternational Journal of Sports Science & Coaching·DateMar 27, 2018

Despite reductions in infectious disease mortality in US, diarrheal disease deaths on the rise

A new study reveals that diarrheal diseases are becoming a major public health concern in the US, with rates increasing substantially between 1980 and 2014. Diarrheal disease deaths were ranked as the second-leading cause of all infectious disease mortality, behind lower respiratory infections such as pneumonia and bronchitis.

Some e-cigarette ingredients are more toxic than others

A new study found that e-liquid ingredients can vary widely in toxicity, with some being more toxic than nicotine alone and propylene glycol and vegetable glycerin. The researchers developed a system to rapidly evaluate e-liquid toxicity using plastic plates with tiny wells containing human cells exposed to different e-liquids.

SourcePLOS·JournalPLOS Biology·DateMar 27, 2018

Tattoo electrodes from an ink-jet printer

Researchers at TU Graz have developed a novel method for creating printed tattoo electrodes that can transmit electrical impulses from human to machine. The electrodes are thin, flexible, and conformable, allowing for accurate measurements over extended periods without restricting patient mobility or comfort.

SourceGraz University of Technology·JournalAdvanced Science·DateMar 27, 2018

High doses of antiviral drug may be effective against Ebola

A new study published in PLOS Medicine found that high doses of antiviral drug favipiravir extended survival in non-human primates infected with Ebola virus. The drug was shown to inhibit viral replication in a drug concentration-dependent manner, with animals treated at higher doses surviving longer than those treated at lower doses.

SourcePLOS·JournalPLOS Medicine·DateMar 27, 2018